Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353501 | 12535350 | 1 | I | 2016 | 20160621 | 20160707 | 20160707 | PER | US-TEVA-671852USA | TEVA | 0.00 | F | Y | 0.00000 | 20160707 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353501 | 12535350 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | U | V02011 | 20622 | 40 | MG | TIW | ||||||
| 125353501 | 12535350 | 2 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 125353501 | 12535350 | 3 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 125353501 | 12535350 | 4 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125353501 | 12535350 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125353501 | 12535350 | Chest discomfort | |
| 125353501 | 12535350 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125353501 | 12535350 | 1 | 20141112 | 0 |